Cargando…
Agonistic anti-ICAM-1 antibodies in scleroderma: Activation of endothelial pro-inflammatory cascades
BACKGROUND: Scleroderma (SSc) is a complex autoimmune disorder that can be characterised by the presence 2of circulating autoantibodies to nuclear, cytoplasmic and cell surface antigens. In particular antibodies directed against endothelial cell antigens (anti-endothelial cell antibodies; AECA) have...
Autores principales: | Wolf, Sabine I., Howat, Sarah, Abraham, David J., Pearson, Jeremy D., Lawson, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731553/ https://www.ncbi.nlm.nih.gov/pubmed/23685129 http://dx.doi.org/10.1016/j.vph.2013.05.002 |
Ejemplares similares
-
ICAM‐1‐targeted nanocarriers attenuate endothelial release of soluble ICAM‐1, an inflammatory regulator
por: Manthe, Rachel L., et al.
Publicado: (2017) -
Endothelial injury in scleroderma
Publicado: (1979) -
Endothelial MAPKs Direct ICAM-1 Signaling to Divergent Inflammatory Functions
por: Dragoni, Silvia, et al.
Publicado: (2017) -
Antiphospholipid Antibodies and Systemic Scleroderma
por: Touré, Awa Oumar, et al.
Publicado: (2013) -
Antiphospholipid Antibodies and Systemic Scleroderma
por: Mubarak, Muhammed, et al.
Publicado: (2013)